VCY1B

Across TCGA pan-cancer cohorts, VCY1B RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated VCY1B data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher VCY1B RNA is associated with worse overall survival. In most high-consensus cancer types, elevated VCY1B expression acts as an unfavorable survival marker.

LUAD, BRCA, and TGCT are the cancer types where VCY1B RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	III,IV	0.057	0.680	<.001	72	view →
BRCA	OS	Tertile	All	0.129	0.579	.003	48	view →
TGCT	DFS	Tertile	III,IV	0.017	0.923	.021	24	view →
LIHC	OS	Tertile	All	0.245	0.709	.030	18	view →
BLCA	DFS	Tertile	IV	0.146	0.482	.005	9	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

VCY1B–LUAD (OS)

Open the LUAD breakdown →